Air Voel Expands Product Line with the Latest ResMed CPAP Machines for Enhanced Sleep Therapy.Canada - November 8, 2024 — Air ...

William Blair sees ResMed well-positioned to capitalize on ... driven by increased demand for sleep devices and masks portfolio and strong growth across the Residential Care Software business.

ResMed shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 82. Meet the ...

The most significant challenge facing ResMed is the potential impact of GLP-1 drugs on its core CPAP device market. Eli Lilly (NYSE:LLY)'s tirzepatide, a GLP-1 medication, is expected to receive ...

Oct 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the ...

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter ... based company makes continuous positive airway pressure devices, or CPAPs. These face-worn masks help ...

as patients become more aware of the disease and doctors use all tools to treat the disease, including ResMed’s CPAP devices.

Sleep devices giant ResMed has brushed off investor fears that transformative weight-loss drugs threaten long-term demand for its sleep apnoea devices after posting better-than-expected first ...

we estimate ResMed’s pricing to be roughly 15% higher than the remaining peer average across the automatic positive airway pressure device category and 30% higher in the CPAP category.

On Thursday, ResMed Inc (NYSE:RMD ... driven by increased demand for sleep devices and masks portfolio and strong growth across the Residential Care Software business. Residential Care Software ...